02:22:39 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-26 Kvartalsrapport 2024-Q2
2024-05-27 X-dag ordinarie utdelning OBSRV 0.00 NOK
2024-05-24 Årsstämma 2024
2024-03-13 Bokslutskommuniké 2023
2023-11-22 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-30 X-dag ordinarie utdelning OBSRV 0.00 NOK
2023-05-26 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Årsstämma 2022
2022-06-03 Kvartalsrapport 2022-Q1
2022-06-03 X-dag ordinarie utdelning OBSRV 0.00 NOK
2022-03-29 Bokslutskommuniké 2021
2022-02-04 Extra Bolagsstämma 2022
2021-11-03 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-25 X-dag ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 Årsstämma 2021
2021-05-12 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-11-03 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-07-01 X-dag ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 Årsstämma 2020
2020-06-16 Extra Bolagsstämma 2020
2020-05-12 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriMedicinteknik
Observe Medical är ett norskt bolag verksamma inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo, Norge.
2024-08-19 16:16:43
Oslo, August 19, 2024 -Observe Medical ("the Company" or "Observe Medical") will
release its results for the first half year 2024 on Monday, 26 Augsut 2024. The
presentation will be published on NewsWeb and theCompany's website at 07:00 CET
on the same day.

The Company will host a presentation and Q&Asession at 10:00 CET on the same
day. Personal attendance is welcomed at Carnegie's offices at Aker Brygge,
Fjordalleen 16.

The session will also be streamed via webcast. To register and follow the
presentation online, please copy and paste the following link into your browser,
click attend and register your e-mail:

https://channel.royalcast.com/landingpage/hegnarmedia/20240826_1/ (https://eur03
.
safelinks.protection.outlook.com/?url=https%3A%2F%2Fchannel.royalcast.com%2Fland
i
ngpage%2Fhegnarmedia%2F20240826_1%2F&data=05%7C02%7Cjohan.fagerli%40observemedic
a
l.com%7Cc2539856390b4690349f08dcbb715558%7C139dbc03ecf246efb467a338c990a8d6%7C0%
7
C0%7C638591342653149017%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2lu
M
zIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=q8l%2B6bRAQEhXQyROB%2BFCyHf
C
lk5uWNUxlXf%2B1YGssXk%3D&reserved=0)

After the live event, the presentation and recording will be made availableunder
the Investor Relations section on the Company's website,

https://observemedical.com/investor-relations/

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.